Stocks
IVERIC bio, Inc.ISEE
NASDAQHealthcareBiotechnology$39.95+0.38%
Focused on developing novel therapies for retinal diseases, this biopharmaceutical company has gained investor attention for its late-stage clinical programs targeting unmet medical needs. Its lead candidate, Zimura, is being evaluated for geographic atrophy secondary to age-related macular degeneration, a market with significant commercial potential.
Market Cap: $5.5B52W Range: $9.39 – $39.99
Congressional Interest in IVERIC bio, Inc. (ISEE)
1 member of Congress has disclosed 2 trades in IVERIC bio, Inc. (ISEE), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
2
Sells
0
Who in Congress Is Trading ISEE?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-10-12 | Christopher L. Jacobs | buy | $1K – $15K |
| 2022-07-18 | Christopher L. Jacobs | buy | $1K – $15K |